BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28414188)

  • 21. Concurrent somatic KRAS mutation and germline 10q22.3-q23.2 deletion in a patient with juvenile myelomonocytic leukemia, developmental delay, and multiple malformations: a case report.
    Yao R; Yu T; Xu Y; Li G; Yin L; Zhou Y; Wang J; Yan Z
    BMC Med Genomics; 2018 Jul; 11(1):60. PubMed ID: 30012129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A new "rasopathy": mutation in the CBL tumour-suppressor gene in neuro-cardio-facio-cutaneous syndrome similar to Noonan syndrome].
    Dereure O
    Ann Dermatol Venereol; 2011 Jan; 138(1):75-6. PubMed ID: 21276471
    [No Abstract]   [Full Text] [Related]  

  • 23. Immune dysregulation associated with co-occurring germline CBL and SH2B3 variants.
    Baccelli F; Leardini D; Muratore E; Messelodi D; Bertuccio SN; Chiriaco M; Cancrini C; Conti F; Castagnetti F; Pedace L; Pession A; Yoshimi A; Niemeyer C; Tartaglia M; Locatelli F; Masetti R
    Hum Genomics; 2022 Sep; 16(1):40. PubMed ID: 36123612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Juvenile myelomonocytic leukemia-associated variants are associated with neo-natal lethal Noonan syndrome.
    Mason-Suares H; Toledo D; Gekas J; Lafferty KA; Meeks N; Pacheco MC; Sharpe D; Mullen TE; Lebo MS
    Eur J Hum Genet; 2017 Apr; 25(4):509-511. PubMed ID: 28098151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myeloproliferative disorder in Noonan syndrome.
    Bastida P; García-Miñaúr S; Ezquieta B; Dapena JL; Sanchez de Toledo J
    J Pediatr Hematol Oncol; 2011 Jan; 33(1):e43-5. PubMed ID: 20829714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular and phenotypic diversity of CBL-mutated juvenile myelomonocytic leukemia.
    Hecht A; Meyer JA; Behnert A; Wong E; Chehab F; Olshen A; Hechmer A; Aftandilian C; Bhat R; Choi SW; Chonat S; Farrar JE; Fluchel M; Frangoul H; Han JH; Kolb EA; Kuo DJ; MacMillan ML; Maese L; Maloney KW; Narendran A; Oshrine B; Schultz KR; Sulis ML; Van Mater D; Tasian SK; Hofmann WK; Loh ML; Stieglitz E
    Haematologica; 2022 Jan; 107(1):178-186. PubMed ID: 33375775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary Graft Failure but Treatment Success: A Case of Reversion to Heterozygosity After Allogeneic Hematopoietic Cell Transplantation With Autologous Hematopoietic Recovery in a Child With CBL-related Juvenile Myelomonocytic Leukemia.
    Oshrine B
    J Pediatr Hematol Oncol; 2021 Apr; 43(3):e426-e428. PubMed ID: 32032248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transient immune deficiency accompanied with homozygous CBL rare variant.
    Morishita A; Yeh TW; Tomari K; Furuichi M; Kashimada K; Morio T; Takagi M; Imai K
    Pediatr Int; 2023 Jan; 65(1):e15439. PubMed ID: 36495474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Juvenile myelomonocytic leukemia in a 16-year-old with Noonan syndrome: case report.
    Ortiz MV; Skoda-Smith S; Rauen KA; Allan RW; Slayton WB
    J Pediatr Hematol Oncol; 2012 Oct; 34(7):569-72. PubMed ID: 22510777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of Two Juvenile Myelomonocytic Leukemia Patients According to Clinical and Genetic Features.
    Tüfekçi Ö; Ören H; Demir Yenigürbüz F; Gözmen S; Karapınar TH; İrken G
    Turk J Haematol; 2015 Jun; 32(2):175-9. PubMed ID: 26316488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A child with juvenile myelomonocytic leukemia possessing a concurrent germline CBL mutation and a NF1 variant of uncertain significance: A rare case with a common problem in the era of high-throughput sequencing.
    Wang WH; Lu MY; Tsai CH; Wang SC; Chou SW; Jou ST
    J Formos Med Assoc; 2021 Apr; 120(4):1148-1152. PubMed ID: 32933826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Juvenile myelomonocytic leukaemia and Noonan syndrome.
    Strullu M; Caye A; Lachenaud J; Cassinat B; Gazal S; Fenneteau O; Pouvreau N; Pereira S; Baumann C; Contet A; Sirvent N; Méchinaud F; Guellec I; Adjaoud D; Paillard C; Alberti C; Zenker M; Chomienne C; Bertrand Y; Baruchel A; Verloes A; Cavé H
    J Med Genet; 2014 Oct; 51(10):689-97. PubMed ID: 25097206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mastocytosis in a Case of Noonan Syndrome Caused by a De Novo Pathogenic
    Kawaguchi T; Okanishi T; Okazaki T; Aoki C; Kasagi N; Adachi K; Yoshida Y; Miyake N; Matsumoto N; Maegaki Y
    Yonago Acta Med; 2023 Nov; 66(4):463-466. PubMed ID: 38028263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RAS diseases in children.
    Niemeyer CM
    Haematologica; 2014 Nov; 99(11):1653-62. PubMed ID: 25420281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transient juvenile myelomonocytic leukemia in the setting of PTPN11 mutation and Noonan syndrome with secondary development of monosomy 7.
    O'Halloran K; Ritchey AK; Djokic M; Friehling E
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28084675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunological and hematological findings as major features in a patient with a new germline pathogenic CBL variant.
    Stellacci E; Carter JN; Pannone L; Stevenson D; Moslehi D; Venanzi S; ; Bernstein JA; Tartaglia M; Martinelli S
    Am J Med Genet A; 2024 Apr; ():e63627. PubMed ID: 38613168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In hematopoietic cells with a germline mutation of CBL, loss of heterozygosity is not a signature of juvenile myelo-monocytic leukemia.
    Strullu M; Caye A; Cassinat B; Fenneteau O; Touzot F; Blauwblomme T; Rodriguez R; Latour S; Petit A; Barlogis V; Galambrun C; Leblanc T; Baruchel A; Chomienne C; Cavé H
    Leukemia; 2013 Dec; 27(12):2404-7. PubMed ID: 23823657
    [No Abstract]   [Full Text] [Related]  

  • 38. Multiple central giant cell granuloma of the jaws: diagnostic signposts of Noonan syndrome and RASopathy.
    Friedrich RE; Rutkowski R; Gosau M
    Oral Maxillofac Surg; 2024 Jun; 28(2):991-997. PubMed ID: 38347383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adult-onset acute myeloid leukaemia in a patient with germline mutation of CBL.
    Ali AM; Cooper J; Walker A; Jones D; Saad A
    Br J Haematol; 2021 Feb; 192(3):665-667. PubMed ID: 33216958
    [No Abstract]   [Full Text] [Related]  

  • 40. Childhood Rhabdomyosarcoma in Association With a RASopathy Clinical Phenotype and Mosaic Germline SOS1 Duplication.
    Salem B; Hofherr S; Turner J; Doros L; Smpokou P
    J Pediatr Hematol Oncol; 2016 Nov; 38(8):e278-e282. PubMed ID: 27258033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.